{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:03:41Z","timestamp":1783667021632,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T00:00:00Z","timestamp":1725235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196516"],"award-info":[{"award-number":["1196516"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2007726"],"award-info":[{"award-number":["2007726"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013207","name":"Reckitt Benckiser Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40264-024-01472-y","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:02:17Z","timestamp":1725271337000},"page":"1293-1306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Paracetamol Dosing Errors in People Aged 12 Years and Over: An Analysis of Over 14,000 Cases Reported to an Australian Poisons Information Centre"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0437-999X","authenticated-orcid":false,"given":"Annabelle S.","family":"Chidiac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6326-4711","authenticated-orcid":false,"given":"Nicholas A.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-2108","authenticated-orcid":false,"given":"Firouzeh","family":"Noghrehchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8946-5079","authenticated-orcid":false,"given":"Rose","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,2]]},"reference":[{"key":"1472_CR1","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ejp.621","volume":"19","author":"K Brune","year":"2015","unstructured":"Brune K, Renner B, Tiegs G. Acetaminophen\/paracetamol: a history of errors, failures and false decisions. Eur J Pain. 2015;19:953\u201365. https:\/\/doi.org\/10.1002\/ejp.621.","journal-title":"Eur J Pain"},{"key":"1472_CR2","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/pds.4997","volume":"29","author":"AG Hopkins","year":"2020","unstructured":"Hopkins AG, Spiller HA, Kistamgari S, et al. Suicide-related over-the-counter analgesic exposures reported to United States poison control centers, 2000\u20132018. Pharmacoepidemiol Drug Saf. 2020;29:1011\u201321. https:\/\/doi.org\/10.1002\/pds.4997.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1472_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/pds.4166","volume":"26","author":"R Gedeborg","year":"2017","unstructured":"Gedeborg R, Svennblad B, Holm L, et al. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol Drug Saf. 2017;26:518\u201327. https:\/\/doi.org\/10.1002\/pds.4166.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1472_CR4","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/00365521.2021.1921254","volume":"56","author":"\u00deA Fri\u00f0riksd\u00f3ttir","year":"2021","unstructured":"Fri\u00f0riksd\u00f3ttir \u00deA, J\u00f3nsd\u00f3ttir F, Snook CP, et al. Paracetamol poisoning: a population-based study from Iceland. Scand J Gastroenterol. 2021;56:832\u20139. https:\/\/doi.org\/10.1080\/00365521.2021.1921254.","journal-title":"Scand J Gastroenterol"},{"key":"1472_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yrtph.2015.05.011","volume":"72","author":"HY Tong","year":"2015","unstructured":"Tong HY, Medrano N, Borobia AM, et al. Hepatotoxicity induced by acute and chronic paracetamol overdose in adults. Where do we stand? Regul Toxicol Pharmacol. 2015;72:370\u20138. https:\/\/doi.org\/10.1016\/j.yrtph.2015.05.011.","journal-title":"Regul Toxicol Pharmacol."},{"key":"1472_CR6","doi-asserted-by":"publisher","first-page":"E542","DOI":"10.1503\/cmaj.210842","volume":"194","author":"T Antoniou","year":"2022","unstructured":"Antoniou T, Guan Q, Martins D, et al. Impact of acetaminophen product labelling changes in Canada on hospital admissions for accidental acetaminophen overdose: a population-based study. Can Med Assoc J. 2022;194:E542\u20138. https:\/\/doi.org\/10.1503\/cmaj.210842.","journal-title":"Can Med Assoc J"},{"key":"1472_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jad.2020.07.091","volume":"276","author":"D Casey","year":"2020","unstructured":"Casey D, Geulayov G, Bale E, et al. Paracetamol self-poisoning: Epidemiological study of trends and patient characteristics from the multicentre study of self-harm in England. J Affect Disord. 2020;276:699\u2013706. https:\/\/doi.org\/10.1016\/j.jad.2020.07.091.","journal-title":"J Affect Disord"},{"key":"1472_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/17425255.2023.2223959","volume":"19","author":"AS Chidiac","year":"2023","unstructured":"Chidiac AS, Buckley NA, Noghrehchi F, et al. Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease. Expert Opin Drug Metab Toxicol. 2023;19:297\u2013317. https:\/\/doi.org\/10.1080\/17425255.2023.2223959.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"1472_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/15563650.2011.554839","volume":"49","author":"MA Alhelail","year":"2011","unstructured":"Alhelail MA, Hoppe JA, Rhyee SH, et al. Clinical course of repeated supratherapeutic ingestion of acetaminophen. Clin Toxicol. 2011;49:108\u201312. https:\/\/doi.org\/10.3109\/15563650.2011.554839.","journal-title":"Clin Toxicol"},{"key":"1472_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","volume":"337","author":"FV Schi\u00f8dt","year":"1997","unstructured":"Schi\u00f8dt FV, Rochling FA, Casey DL, et al. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997;337:1112\u20138. https:\/\/doi.org\/10.1056\/NEJM199710163371602.","journal-title":"N Engl J Med"},{"key":"1472_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/15563650.2018.1547829","volume":"57","author":"H Egan","year":"2019","unstructured":"Egan H, Isbister GK, Robinson J, et al. Retrospective evaluation of repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol. 2019;57:703\u201311. https:\/\/doi.org\/10.1080\/15563650.2018.1547829.","journal-title":"Clin Toxicol"},{"key":"1472_CR12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ajem.2010.08.006","volume":"29","author":"J Vogel","year":"2011","unstructured":"Vogel J, Heard KJ, Carlson C, et al. Dental pain as a risk factor for accidental acetaminophen overdose: a case-control study. Am J Emerg Med. 2011;29:1125\u20139. https:\/\/doi.org\/10.1016\/j.ajem.2010.08.006.","journal-title":"Am J Emerg Med"},{"key":"1472_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.annemergmed.2004.05.005","volume":"44","author":"FFS Daly","year":"2004","unstructured":"Daly FFS, O\u2019Malley GF, Heard K, et al. Prospective evaluation of repeated supratherapeutic acetaminophen (paracetamol) ingestion. Ann Emerg Med. 2004;44:393\u20138. https:\/\/doi.org\/10.1016\/j.annemergmed.2004.05.005.","journal-title":"Ann Emerg Med"},{"key":"1472_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/cc1475","volume":"6","author":"GG Gyamlani","year":"2002","unstructured":"Gyamlani GG, Parikh CR. Acetaminophen toxicity: suicidal vs accidental. Crit Care. 2002;6:155. https:\/\/doi.org\/10.1186\/cc1475.","journal-title":"Crit Care"},{"key":"1472_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1331\/JAPhA.2010.08175","volume":"50","author":"LB Hornsby","year":"2010","unstructured":"Hornsby LB, Whitley HP, Hester EK, et al. Survey of patient knowledge related to acetaminophen recognition, dosing, and toxicity. J Am Pharm Assoc (2003). 2010;50:485\u20139. https:\/\/doi.org\/10.1331\/JAPhA.2010.08175.","journal-title":"J Am Pharm Assoc"},{"key":"1472_CR16","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s11606-012-2096-3","volume":"27","author":"MS Wolf","year":"2012","unstructured":"Wolf MS, King J, Jacobson K, et al. Risk of unintentional overdose with non-prescription acetaminophen products. J Gen Intern Med. 2012;27:1587\u201393. https:\/\/doi.org\/10.1007\/s11606-012-2096-3.","journal-title":"J Gen Intern Med"},{"key":"1472_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01.NPR.0000586020.15798.c6","volume":"44","author":"SJ Saccomano","year":"2019","unstructured":"Saccomano SJ. Acute acetaminophen toxicity in adults. Nurse Pract. 2019;44:42\u20137. https:\/\/doi.org\/10.1097\/01.NPR.0000586020.15798.c6.","journal-title":"Nurse Pract"},{"key":"1472_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccc.2012.07.006","volume":"28","author":"MJ Hodgman","year":"2012","unstructured":"Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin. 2012;28:499\u2013516. https:\/\/doi.org\/10.1016\/j.ccc.2012.07.006.","journal-title":"Crit Care Clin"},{"key":"1472_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5694\/mja2.50296","volume":"211","author":"R Cairns","year":"2019","unstructured":"Cairns R, Brown JA, Wylie CE, et al. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004\u20132017. Med J Aust. 2019;211:218\u201323. https:\/\/doi.org\/10.5694\/mja2.50296.","journal-title":"Med J Aust"},{"key":"1472_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/jgh.12196","volume":"28","author":"S Sood","year":"2013","unstructured":"Sood S, Howell J, Sundararajan V, et al. Paracetamol overdose in Victoria remains a significant health-care burden. J Gastroenterol Hepatol. 2013;28:1356\u201360. https:\/\/doi.org\/10.1111\/jgh.12196.","journal-title":"J Gastroenterol Hepatol"},{"key":"1472_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5694\/mja2.50428","volume":"212","author":"AL Chiew","year":"2020","unstructured":"Chiew AL, Reith D, Pomerleau A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212:175\u201383. https:\/\/doi.org\/10.5694\/mja2.50428.","journal-title":"Med J Aust"},{"key":"1472_CR22","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1080\/15563650.2019.1686513","volume":"58","author":"A Huynh","year":"2020","unstructured":"Huynh A, Cairns R, Brown JA, et al. Health care cost savings from Australian Poisons Information Centre advice for low risk exposure calls: SNAPSHOT 2. Clin Toxicol. 2020;58:752\u20137. https:\/\/doi.org\/10.1080\/15563650.2019.1686513.","journal-title":"Clin Toxicol"},{"key":"1472_CR23","unstructured":"Australian Bureau of Statistics. National, state and territory population. https:\/\/www.abs.gov.au\/statistics\/people\/population\/national-state-and-territory-population. Accessed 12 May 2024."},{"key":"1472_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5694\/mja17.01063","volume":"209","author":"A Huynh","year":"2018","unstructured":"Huynh A, Cairns R, Brown JA, et al. Patterns of poisoning exposure at different ages: the 2015 annual report of the Australian Poisons Information Centres. Med J Aust. 2018;209:74\u20139. https:\/\/doi.org\/10.5694\/mja17.01063.","journal-title":"Med J Aust"},{"key":"1472_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","volume":"22","author":"EB Wilson","year":"1927","unstructured":"Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209\u201312. https:\/\/doi.org\/10.1080\/01621459.1927.10502953.","journal-title":"J Am Stat Assoc"},{"key":"1472_CR26","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873\u201390. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19980430)17:8%3c873::AID-SIM779%3e3.0.CO;2-I.","journal-title":"Stat Med"},{"key":"1472_CR27","volume-title":"Nonparametric statistical methods","author":"M Hollander","year":"1973","unstructured":"Hollander M, Wolfe DA. Nonparametric statistical methods. 1st ed. New York: Wiley; 1973.","edition":"1"},{"key":"1472_CR28","unstructured":"Therapeutic Goods Administration. 1.4. Final decision in relation to paracetamol (modified release). 2019. https:\/\/www.tga.gov.au\/resources\/publication\/scheduling-decisions-final\/notice-final-decision-amend-or-not-amend-current-poisons-standard-august-2019\/14-final-decision-relation-paracetamol-modified-release. Accessed 31 August 2022."},{"key":"1472_CR29","unstructured":"NPS MedicineWise. Rates of paracetamol overdose continue to rise in Australia. 2019. https:\/\/www.nps.org.au\/news\/paracetamol-overdoses-rise. Accessed 6 May 2024."},{"key":"1472_CR30","unstructured":"Therapeutic Goods Administration. Database of Adverse Event Notifications (DAEN) - medicines. https:\/\/daen.tga.gov.au\/medicines-search\/. Accessed 9 May 2024."},{"key":"1472_CR31","unstructured":"Therapeutic Goods Administration. Final decision on re-scheduling of codeine: frequently asked questions. 2016. https:\/\/www.tga.gov.au\/final-decision-re-scheduling-codeine-frequently-asked-questions. Accessed 15 November 2023."},{"key":"1472_CR32","unstructured":"Therapeutic Goods Administration. TGA makes final decision to reduce paracetamol pack sizes. 2023. https:\/\/www.tga.gov.au\/news\/media-releases\/tga-makes-final-decision-reduce-paracetamol-pack-sizes. Accessed 15 November 2023."},{"key":"1472_CR33","unstructured":"Therapeutic Goods Administration. Active ingredient prominence. 2013. https:\/\/www.tga.gov.au\/labelling-and-packaging-practices-summary-some-evidence\/active-ingredient-prominence. Accessed 26 October 2023."},{"key":"1472_CR34","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3109\/15563650.2015.1098657","volume":"53","author":"J-A Rotella","year":"2015","unstructured":"Rotella J-A, Wong A, Howell J, et al. High-visibility warning labels on paracetamol-containing products do not prevent supratherapeutic ingestion in a simulated scenario. Clin Toxicol. 2015;53:935\u201340. https:\/\/doi.org\/10.3109\/15563650.2015.1098657.","journal-title":"Clin Toxicol"},{"key":"1472_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.5694\/mja2.50992","volume":"214","author":"C Abdel Shaheed","year":"2021","unstructured":"Abdel Shaheed C, Ferreira GE, Dmitritchenko A, et al. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews. Med J Aust. 2021;214:324\u201331. https:\/\/doi.org\/10.5694\/mja2.50992.","journal-title":"Med J Aust"},{"key":"1472_CR36","unstructured":"Australian Prudential Regulation Authority. Quarterly private health insurance statistics December 2023. 2024. https:\/\/www.apra.gov.au\/sites\/default\/files\/2024-02\/Quarterly%20Private%20Health%20Insurance%20Statistics%20December%202023_0.pdf. Accessed 5 May 2024."},{"key":"1472_CR37","unstructured":"Australian Institute of Health and Welfare. Oral health and dental care in Australia. https:\/\/www.aihw.gov.au\/reports\/dental-oral-health\/oral-health-and-dental-care-in-australia\/contents\/costs. Accessed 5 May 2024."},{"key":"1472_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cgh.2008.02.053","volume":"6","author":"RP Myers","year":"2008","unstructured":"Myers RP, Shaheen AAM, Li B, et al. Impact of liver disease, alcohol abuse, and unintentional ingestions on the outcomes of acetaminophen overdose. Clin Gastroenterol Hepatol. 2008;6:918\u201325. https:\/\/doi.org\/10.1016\/j.cgh.2008.02.053.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1472_CR39","unstructured":"Buckley N, Calear A, Cairns R, et al. Independent expert report on the risks of intentional self-poisoning with paracetamol. 2022. https:\/\/www.tga.gov.au\/sites\/default\/files\/2022-09\/paracetamol_report_final.pdf. Accessed 23 September 2022."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-024-01472-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-024-01472-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T14:09:40Z","timestamp":1731334180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-024-01472-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,2]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1472"],"URL":"https:\/\/doi.org\/10.1007\/s40264-024-01472-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,2]]},"assertion":[{"value":"28 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. RC is supported by an NHMRC Investigator Grant (ID: 1196516), NAB is supported by an NHMRC Investigator Grant (ID: 2007726). RC is the recipient of an untied educational grant from Reckitt Benckiser to study over-the-counter medicine poisonings, which includes a PhD stipend for ASC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"ASC is supported by a PhD scholarship funded by Reckitt Benckiser, as part of an untied educational grant awarded to RC. RC has also received conference speaker fees\/honoraria from Reckitt Benckiser and The Pharmacy Guild of Australia. These funders had no role in the design, conduct, or interpretation of the study\u2019s findings. NAB is an Editorial Board member of Drug Safety. NAB was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. FN has no conflicts of interest to be declared.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The data supporting this study\u2019s findings are not publicly available due to the sensitive nature of the contents. Select data is available on request to the NSW Poisons Information Centre. For access, please email rose.cairns@sydney.edu.au","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was approved by the Sydney Children\u2019s Hospitals Network Human Research Ethics Committee (2021\/ETH00165).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"R code used for the Wilcoxon Rank Sum test is available on request. For access, please email firouzeh.noghrehchi@sydney.edu.au","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"RC and NAB contributed to the design of the study. Data cleaning and extraction was performed by ASC. ASC and FN performed the data analysis. The first draft of the manuscript was written by ASC and all authors commented on subsequent versions of the manuscript. All authors read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}